Dr. Vinnedge tests novel breast cancer therapeutics and works to identify biomarkers of disease and disease progression from patient samples.

Ashley has a BS in biological studies from the University of Cincinnati. She starting working at Cincinnati Children’s Hospital in 2016 and joined the Privette Vinnedge lab in 2022. She uses cell culture and mouse models to understand the molecular mechanism that drive DEK-induced proliferation in mammary epithelial cells.

Evan Page joined the team in the spring of 2022 as a student II position. He is currently a senior at Northern Kentucky University and is pursuing a degree in biological sciences with a focus in biochemistry. He provides valuable technical assistance to support the lab and studies the oncogenic mechanisms of DEK over-expression.

Sophia Schutte is an undergraduate student at Xavier University pursuing a degree in biomedical sciences. She joined the lab for the Summer Undergraduate Research Fellowship (SURF) in the summer of 2022. She continues to support the lab during the academic year providing technical assistance to understand the molecular mechanism that drive DEK-induced proliferation in mammary epithelial cells and the oncogenic mechanisms of DEK over-expression.